Molbio Diagnostics Ltd (MOLB)

Currency in INR
807.00
0.00(0.00%)
Closed·
Trading near 52-week High
Trading near 52-week Low
MOLB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
807.00807.00
52 wk Range
807.00807.00
Key Statistics
Prev. Close
807
Open
807
Day's Range
807-807
52 wk Range
807-807
Volume
-
Average Volume (3m)
-
1-Year Change
-
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MOLB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Currently not supported.
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

MOLB Income Statement

Compare MOLB to Peers and Sector

Metrics to compare
MOLB
Peers
Sector
Relationship
P/E Ratio
0.0x16.7x−0.4x
PEG Ratio
0.000.070.00
Price/Book
0.0x1.8x2.6x
Price / LTM Sales
0.0x2.0x3.1x
Upside (Analyst Target)
0.0%47.1%47.8%
Fair Value Upside
Unlock7.1%6.2%Unlock

Molbio Diagnostics Limited, a point-of-care diagnostics company, provides healthcare technologies to diagnose infectious and non-communicable diseases. It manufactures and sells chip based diagnostic devices, chips and reagents, X-ray equipment's, and single/dual detectors. It also offers disposable POCT devices, which includes dengue, malaria, and COVID-19 tests; Tabletop analysers, a portable machine that are used to perform molecular or immunodiagnostic tests to detect infectious diseases, such as tuberculosis, human papillomavrus, STIs, and GI disorders. In addition, the company offers Truenat, a multi-disease real-time polymerase chain reaction platform that enables treatment decisions for various infectious and non-communicable diseases, such as tuberculosis, human immunodeficiency virus, malaria, viral hepatitis, COVID-19, dengue, chikungunya, influenza, H1N1, HPV/cervical cancer, cholera, leprosy, etc.; and Truenat assays. The company was incorporated in 2000 and is based in Verna, India.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
87.04M75.53%70.24B
Public Companies & Retail Investors
28.20M24.47%22.75B
Total
115.24M100.00%93B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Exxora Trading LLP40.34%46,487,60037,515,493
India Business Excellence Fund-III12.39%14,276,75011,521,337

FAQ

What Is the Molbio Diagnostics (MOLB) Stock Price Today?

The Molbio Diagnostics stock price today is 807.00 INR.

What Stock Exchange Does Molbio Diagnostics Trade On?

Molbio Diagnostics is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Molbio Diagnostics?

The stock symbol for Molbio Diagnostics is "MOLB."

What Is the Molbio Diagnostics Market Cap?

As of today, Molbio Diagnostics market cap is 0.00 INR.

What Is Molbio Diagnostics's Earnings Per Share (TTM)?

The Molbio Diagnostics EPS (TTM) is 12.87.

How Many Times Has Molbio Diagnostics Stock Split?

Molbio Diagnostics has split 0 times.

What is the current trading status of Molbio Diagnostics (MOLB)?

As of Aug 16, 2026, Molbio Diagnostics (MOLB) is trading at a price of 807.00 INR, with a previous close of 807.00 INR. The stock has fluctuated within a day range of 807.00 INR to 807.00 INR, while its 52-week range spans from 807.00 INR to 807.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.